TITLE

Review: Low-molecular-weight heparin reduces recurrent venous thromboembolism better than unfractionated heparin

PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p71
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents a study, which reports that low-molecular-weight heparin (LMVH) reduces recurrent venous thromboembolism (VTE) better than unfractionated heparin (UFH). The study method consisted of randomized controlled trials that compared fixed-dose subcutaneous LMWH with adjusted-dose UFH for initial treatment in patients with acute VTE. Categories of VTE included symptomatic deep venous thrombosis (DVT) of the leg without symptoms of pulmonary embolism (PE); symptomatic DVT of the leg with or without symptomatic PE; or asymptomatic DVT of the leg with symptomatic PE or symptomatic DVT or PE.
ACCESSION #
17116536

 

Related Articles

  • Pentasaccharides: a New Class of Anticoagulants in Clinical Practice. Abdel-Razeq, Hikmat // Journal of Coagulation Disorders;2010, Vol. 2 Issue 1, p1 

    Venous thromboembolism (VTE) remains a common but preventable disease. Increasing focus on simplicity and efficacy has led to the introduction of a new group of anticoagulants, the synthetic pentasaccharides, substances that specifically inhibit factor Xa activity, producing an antithrombotic...

  • Pentasaccharides: a New Class of Anticoagulants in Clinical Practice. Abdel-Razeq, Hikmat // Journal of Coagulation Disorders;2010, Vol. 2 Issue 2, p1 

    Venous thromboembolism (VTE) remains a common but preventable disease. Increasing focus on simplicity and efficacy has led to the introduction of a new group of anticoagulants, the synthetic pentasaccharides, substances that specifically inhibit factor Xa activity, producing an antithrombotic...

  • Spontaneous superficial venous thrombophlebitis: Does it increase risk for thromboembolism? van Weert, H.; Dolan, G.; Wichers, I.; de Vries, C.; ter Riet, G.; Buller, H. // Journal of Family Practice;Jan2006, Vol. 55 Issue 1, p52 

    Objectives To determine the risk of arterial and venous complications after a spontaneous superficial venous thrombophlebitis (SVTP) in the leg in a general practice population. Study design Retrospective cohort study (LOE: 2b [CEBM]). Exposure consisted of the diagnosis of SVTP of the lower...

  • FOREWORD. Kakkar, Vijay V. // Drugs;2010 Supplement 2, Vol. 70, p1 

    A foreword to the December 14, 2010 issue of the journal "Drugs" is presented.

  • New Anticoagulants: Focus on Venous Thromboembolism. G�mez-Outes, Antonio; Lecumberri, Ram�n; Pozo, Carmen; Rocha, Eduardo // Current Vascular Pharmacology;Jul2009, Vol. 7 Issue 3, p309 

    Anticoagulation is recommended for prophylaxis and treatment of venous thromboembolism (VTE) (deep vein thrombosis and pulmonary embolism) and/or arterial thromboembolism. The therapeutic arsenal of anticoagulants available to clinicians is mainly composed by unfractionated heparin (UFH),...

  • The ethical decisions UK doctors make regarding advanced cancer patients at the end of life - the perceived (in) appropriateness of anticoagulation for venous thromboembolism: A qualitative study. Sheard, Laura; Prout, Hayley; Dowding, Dawn; Noble, Simon; Watt, Ian; Maraveyas, Anthony; Johnson, Miriam // BMC Medical Ethics;2012, Vol. 13 Issue 1, p22 

    Background: Cancer patients are at risk of developing blood clots in their veins - venous thromboembolism (VTE) - which often takes the form of a pulmonary embolism or deep vein thrombosis. The risk increases with advanced disease. Evidence based treatment is low molecular weight heparin (LMWH)...

  • Dalteparin reduced recurrent venous thromboembolism more than oral anticoagulation in patients with cancer.  // ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p10 

    This article focuses on a study regarding low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer, published in the 2003 issue of "New England Journal of Medicine." 676 patients who had active cancer and symptomatic proximal...

  • Challenging pulmonary embolism - A new generation of oral anticoagulants. Barra, Sérgio; Paiva, Luís; Providência, Rui // Journal of Thoracic Disease;Jun2012, Vol. 4 Issue 3, p244 

    The article highlights the need for early and accurate diagnosis of acute pulmonary embolism (PE). It discusses the role of anticoagulant treatment in management of patients with PE. Studies showing promising results for the use of oral anticoagulants such as dabigatran, a selective thrombin...

  • Home Therapy With LMWH in Deep Vein Thrombosis: Randomized Study Comparing Single and Double Daily Administrations. Bellosta, Raffaello; Ferrari, Patrizio; Luzzani, Luca; Carugati, Claudio; Cossu, Luisa; Talarico, Matteo; Sarcina, Antonio // Angiology;Jun/Jul2007, Vol. 58 Issue 3, p316 

    The aim of this study was to assess the effectiveness of low-molecular-weight heparin (LMWH) treatment of deep vein thrombosis (DVT) in terms of the evolution of thrombosis, the incidence of adverse events, and compliance with heparin treatment using 2 types of LMWH available on the market...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics